Natalie
banner
natalieupright.bsky.social
Natalie
@natalieupright.bsky.social
Study of 2713 GN-BSI patients showed no change in 30-day mortality (10.7% vs 11.6%, p=0.467) but reduced MDR emergence (11% vs 6.5%, p<0.001) after implementing a management bundle. 📉💊##idsky
Implementation of a bundle for the management of patients with Gram-negative bloodstream infection: a pre-post quasi-experimental study
Lack of international guidelines for Gram-negative bloodstream infection (GN-BSI) management poses clinical challenges. We aimed to assess whether implementing a management bundle for GN-BSI patients affected mortality and/or emergence of multidrug resistance (MDR).MethodsSingle-center, quasi-experimental study including adult patients hospitalized with monomicrobial GN-BSI. In the pre-phase (2018-2019), no standardized protocol was used. In the post-phase (2022–2023), a bundle was applied including predefined rules for follow-up blood cultures (FU-BC), imaging, beta-lactam administration schedule and treatment duration. Primary endpoint was 30-day all-cause mortality; secondary endpoint was 30-day MDR-GN carriage or infection. Treatment-effect lasso models were used to estimate bundle impact.ResultsA total of 2713 patients were included: 1430 in the pre-phase and 1253 in the post-phase. FU-BCs were performed in 22.5% (n=322) vs 47% (n=589), p<0.001; imaging in 65.5% (n 936) vs 71.6% (n=897), p<0.001; median treatment duration was 10 days in both phases (p=0.625). Thirty-day mortality was 10.7% (n=153) vs 11.6% (n=143), p=0.467. New MDR carriage/infection was 140 (11.0%) vs 78 (6.5%), p<0.001. The bundle had no overall effect on 30-day mortality (ATE = 0.008, p=0.568), despite reduced mortality in BSIs due to carbapenem-resistant organisms (ATE = -0.074, p=0.197) the effect was not significant. MDR emergence was significantly reduced (ATE = -0.038, p=0.031) in both overall and high-risk populations.ConclusionsThe GN-BSI management bundle reduced MDR.
academic.oup.com
November 16, 2025 at 4:34 AM
November 16, 2025 at 4:33 AM
Microevolutionary Models and Multi-omics Analysis Uncover The Cross-drug Resistance Characteristics of Capreomycin-selected #Mycobacterium #tuberculosis

www.sciencedirect.com/science/arti... #OpenAccess #TB #MicroSky #IDSky
November 16, 2025 at 4:31 AM
How to approach a patient hospitalized for pneumonia who is not responding to treatment?
➡️Differential diagnosis
➡️Diagnostic workup

⚠️Escalating antibiotic treatment should not be the default option

doi.org/10.1007/s001...

#IDSky
November 16, 2025 at 4:28 AM
Impact of discontinuation of contact precautions on healthcare-associated ESBL-producing Escherichia coli in a large tertiary care hospital: an interrupted time-series analysis

✅ Just Accepted
🔗 https://bit.ly/47t7eEk
November 11, 2025 at 3:12 PM
When emerging fungal infections mimic tuberculosis: first reported case of invasive Emergomyces europaeus infection in a man with immunocompromise living in France

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nIUDnB
November 11, 2025 at 3:08 PM
Healio: 'Study: Reinfection doubles children’s risk for long COVID'

"Eventually, hopefully, we can figure out how to better treat the different forms of long COVID.” - Ravi Jhaveri, MD, head of the division of infectious diseases, Lurie Children’s Hospital of Chicago

www.healio.com/news/pediatr...
Study: Reinfection doubles children’s risk for long COVID
Getting COVID-19 twice doubled children and adolescents&rsquo; risk for developing long COVID, according to data from the RECOVER trial published in The Lancet Infectious Diseases.Before this study, R...
www.healio.com
November 11, 2025 at 3:08 PM
COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema.

“Our study suggests that COVID-19 vaccination not only protects against coronavirus but may also have broader health benefits for children with atopic dermatitis"
COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema - ACAAI Patient
Children with eczema may experience fewer allergic complications if they receive the COVID-19 vaccine, according to new research.
acaai.org
November 11, 2025 at 3:08 PM
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
November 11, 2025 at 3:06 PM
November 11, 2025 at 3:06 PM
HIV resistance to antiretrovirals can undermine the health benefits conferred by ART. In CID, Ingrid A Beck and colleagues hypothesized that #HIV-dolutegravir-resistance is more frequent when co-administered with nucleos(t)ides with shorter intracellular half-lives. https://bit.ly/4gmBKE0
HIV resistance to dolutegravir varies with co-administered agents
academic.oup.com
November 11, 2025 at 3:05 PM
“Antimicrobial resistance is escalating, but the pipeline of new treatments and diagnostics is insufficient to tackle the spread of drug-resistant bacterial infections,” said Yukiko Nakatani, the WHO’s assistant director-general for health systems division, in a statement.”
WHO says the antibacterial pipeline reveals a dual crisis: scarcity and lack of innovation
A new report finds there are fewer antibacterial medicines in clinical pipelines than just two years ago and relatively few qualify as innovative.
www.statnews.com
November 11, 2025 at 3:05 PM
“Alberta is reporting its first measles death since outbreaks of the highly contagious illness began in the province in March.
The province says a baby, who was born prematurely after the mother became sick, died shortly after birth.” Just devastating… The best way to prevent measles is the vaccine.
Premature baby dies of measles in Alberta outbreak's first death | CBC News
Alberta is reporting its first measles death since outbreaks of the highly contagious illness began in March. The province says a baby, who was born prematurely after the mother became sick, died shor...
www.cbc.ca
November 11, 2025 at 3:05 PM
Gut microbiota predicts the risk of future COVID-19 hospitalization and mortality: insights from the population-based HELIUS Study

✅ Just Accepted
🔗 https://bit.ly/47Ag2IA
November 11, 2025 at 3:04 PM